Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS (2018a) Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health 39:193–213
Abrams DB, Glasser AM, Villanti AC, Pearson JL, Rose S, Niaura RS (2018b) Managing nicotine without smoke to save lives now: evidence for harm minimization. Prev Med 117:88–97
Akiyama Y, Sherwood N (2021) Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicol Rep 8:282–294
Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303
Benowitz NL, St. Helen G, Liakoni E (2021) Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): implications for benefits and risks in the promotion of the combusted tobacco endgame. The Journal of Clinical Pharmacology 61: S18-S36.
Buchhalter AR, Goldenson NI, Kim E, Chan S, Cohen G, Henningfield JE (2020) Pharmacokinetics and subjective effects of the jl electronic nicotine delivery system (ENDS) Compared to five ENDS, a Heated tobacco product, and a combustible cigarette. poster presented at the College for Problems on Drug Dependence, Hollywood, FL. https://www.juullabsscience.com/wp-content/uploads/sites/8/2020/09/CPDD-Pharmacokinetics-and-Subjective-Effects-of-the-JL-Electronic-Nicotine-Delivery-System-ENDS-Compared-to-Five-ENDS-a-Heated-Tobacco-Product-and-a-Combustible-Cigarette.pdf. Accessed Sept 7, 2021.
Caldwell B, Sumner W, Crane J (2012) A systematic review of nicotine by inhalation: is there a role for the inhaled route? Nicotine Tob Res 14:1127–1139
Carstens EE, Carstens MI (2021) Sensory effects of nicotine and tobacco. Nicotine Tob Res: ntab086.
Cobb CO, Foulds J, Yen M-S, Veldheer S, Lopez AA, Yingst JM, Bullen C, Kang L, Eissenberg T, Allen SI, Brosnan P, Bullen C, Chowdhury N, Cobb CO, Eissenberg T, Foulds J, Graham JT, Hammett E, Hrabovsky S, Hummer BL, Kang L, Lester C, Lopez AA, Richie JP, Sciamanna C, Sun S, Lipato T, Veldheer S, Yen M-S, Yingst JM (2021) Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial. Lancet Respir Med 21:S2213-2600
Dawkins L, Cox S, Goniewicz M, McRobbie H, Kimber C, Doig M, Kosmider L (2018) “Real-world” compensatory behaviour with low nicotine concentration e-liquid: subjective effects and nicotine, acrolein and formaldehyde exposure. Addiction 113:1874–1882
de Wit H, Bodker B, Ambre J (1992) Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology 107:352–358
Ebajemito JK, McEwan M, Gale N, Camacho OM, Hardie G, Proctor CJ (2020) A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes. Sci Rep 10:19980
Evans AT, Henderson KC, Geier A, Weaver SR, Spears CA, Ashley DL, Fritz M, John L, Pechacek TF (2020) What Motivates Smokers to Switch to ENDS? A Qualitative Study of Perceptions and Use. Int J Environ Res Public Health 17:8865
Floyd EL, Queimado L, Wang J, Regens JL, Johnson DL (2018) Electronic cigarette power affects count concentration and particle size distribution of vaping aerosol. PLoS One 13: e0210147.
Food and Drug Administration (2001) Guidance for industry: Statistical approaches to establishing bioequivalence. FDA, Washington, DC. https://www.fda.gov/media/70958/download. Published January, 2021. Accessed June 17, 2021.
Food and Drug Administration (2019) Technical Project Lead Review - IQOS Tobacco Heating System, Silver Spring, MD 20993. https://www.fda.gov/media/139796/download. Published July 7, 2020. Accessed June 17, 2021.
Food and Drug Administration (2020) Technical Project Lead review – IQOS tobacco heating system. Sil- ver Spring, MD: FDA; 2019. https://www.fda.gov/me- dia/139796/download. Published July 7, 2020. Accessed June 17, 2021.
Gades MS, Petersen A, Meier E, Lindgren BR, O'Connor RJ, Shields PG, Hatsukami D (2020) The role of subjective responses in electronic cigarette uptake and substitution in adult smokers. Drug Alcohol Depend 212: 107999.
Goldenson NI, Buchhalter AR, Augustson EM, Rubinstein ML, Henningfield JE (2020) Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers. Drug Alcohol Depend 217:108395
Goldenson NI, Buchhalter AR, Augustson EM, Rubinstein ML, Van Hoof D, Henningfield JE (2020) Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system. Drug Alcohol Depend 217:108441
Goldenson NI, Fearon IM, Buchhalter AR, Heningfield JE (2021b) An Open-Label, Randomised, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers. Nicotine Tob Res 23:947–955
Goldenson NI, Shiffman S, Hatcher H, Lamichhane D, Gaggar A, Le GM, Prakash S, Augustson EM (2021c) Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System. Am J Health Behav 45:443–463
Goldenson NI, Ding Y, Prakash S, Hatcher C, Augustson EM, Shiffman S (2021a) Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom. Nicotine Tob Res 23: ntab062.
Gottlieb S, Zeller M (2017) A Nicotine-Focused Framework for Public Health. N Engl J Med 377:1111–1114
Hatsukami DK, Zhang Y, O’Connor RJ, Severson HH (2013) Subjective responses to oral tobacco products: scale validation. Nicotine Tob Res 15:1259–1264
Hiler M, Karaoghlanian N, Talih S, Maloney S, Breland A, Shihadeh A, Eissenberg T (2020) Effects of electronic cigarette heating coil resistance and liquid nicotine concentration on user nicotine delivery, heart rate, subjective effects, puff topography, and liquid consumption. Exp Clin Psychopharmacol 28:527–539
Hummel T, Livermore A, Hummel C, Kobal G (1992) Chemosensory event-related potentials in man: relation to olfactory and painful sensations elicited by nicotine. Electroencephalography and Clinical Neurophysiology/evoked Potentials Section 84:192–195
Jacobson K, Martinez J, Larroque S, Jones IW, Paschke T (2021) Nicotine pharmacokinetics of electronic cigarettes: A pooled data analysis from the literature. Toxicol Rep 8:84–95
Kalman D (2002) The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine Tob Res 4:25–70
Kalman D, Smith SS (2005) Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers. Nicotine Tob Res 7:317–333
Kosmider L, Spindle TR, Gawron M, Sobczak A, Goniewicz ML (2018) Nicotine emissions from electronic cigarettes: Individual and interactive effects of propylene glycol to vegetable glycerin composition and device power output. Food Chem Toxicol 115:302–305
Leavens ELS, Nollen N, Ahluwalia JS, Mayo MS, Rice M, Brett EI, Pulvers K (2021) Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod-based e-cigarettes. Addiction. https://doi.org/10.1111/add.15597
Leventhal AM, Goldenson NI, Barrington-Trimis JL, Pang RD, Kirkpatrick MG (2019) Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers. Drug Alcohol Depend 203:99–106
Leventhal AM, Mason TB, Kirkpatrick MG, Anderson MK, Levine MD (2020) E-cigarette device power moderates the effects of non-tobacco flavors and nicotine on product appeal in young adults. Addict Behav 107:106403
Mallock N, Pieper E, Hutzler C, Henkler-Stephani F, Luch A (2019) Heated Tobacco Products: A Review of Current Knowledge and Initial Assessments. Front Public Health 7:287
Maloney SF, Breland A, Soule EK, Hiler M, Ramôa C, Lipato T, Eissenberg T (2019) Abuse liability assessment of an electronic cigarette in combustible cigarette smokers. Exp Clin Psychopharmacol 27:443–454
Maloney S, Eversole A, Crabtree M, Soule E, Eissenberg T, Breland A (2020) Acute effects of JUUL and IQOS in cigarette smokers. Tob Control: tobaccocontrol-2019–055475.
National Academies of Sciences, Engineering, and Medi- cine, Health and Medicine Division, Board on Popula- tion Health and Public Health Practice, Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems, Eaton DL, Kwan KY, Stratton K, eds. Public Health Consequences of E-Cigarettes. Washington, DC: National Academies Press; 2018
Peace MR, Mulder HA, Baird TR, Butler KE, Friedrich AK, Stone JW, Turner JBM, Poklis A, Poklis JL (2018) Evaluation of Nicotine and the Components of e-Liquids Generated from e-Cigarette Aerosols. J Anal Toxicol 42:537–543
Pearson JL, Zhou Y, Smiley SL, Rubin LF, Harvey E, Koch B, Niaura R, Abrams DB (2020) Intensive longitudinal study of the relationship between cigalike e-cigarette use and cigarette smoking among adult cigarette smokers without immediate plans to quit smoking. Nicotine Tob Res 23:527–534
Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Hajek P (2021) Nicotine delivery and user ratings of IQOS heated tobacco system compared to cigarettes, Juul and refillable e-cigarettes. Nicotine Tob Res: ntab094.
Shiffman S, Goldenson NI, Hatcher C, Augustson EM (2021) Changes in Dependence as Smokers Switch from Cigarettes to JUUL in Two Nicotine Concentrations. Am J Health Behav 45:563–575
Talih S, Balhas Z, Eissenberg T, Salman R, Karaoghlanian N, El Hellani A, Baalbaki R, Saliba N, Shihadeh A (2014) Effects of User Puff Topography, Device Voltage, and Liquid Nicotine Concentration on Electronic Cigarette Nicotine Yield: Measurements and Model Predictions. Nicotine Tob Res 17:150–157
The European Parliament and the Council of the European Union (2014). The approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. In: The European Parliament and the Council of the European Union, ed. Official Journal of the European Union. https://eur-lex.europa.eu/legal-content/en/TXT/?uri=CELEX%3A32014L0040. Accessed September 7, 2021.
US Department of Health and Human Services (2014) The health consequences of smoking—50 years of progress: a report of the Surgeon General. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. US. In: Government Printing Office, Washington, D.C.